|
2013 |
The Role of IL-6 Signaling in Cancer-induced Bone Pain |
$70,501 |
Research |
University of New England |
Bone |
|
|
2013 |
The Role of IL-6 Signaling in Cancer-induced Bone Pain |
$70,501 |
Research |
University of New England |
Bone |
 |
|
2013 |
New Models for Lung Cancer Research |
$59,518 |
Research |
The Jackson Laboratory |
Lung |
|
|
2013 |
Improving the Treament of Cancer Related Pain |
$22,540 |
Research |
University of New England |
Bone |
|
|
2013 |
New Models for Lung Cancer Research |
$59,518 |
Research |
The Jackson Laboratory |
Lung |
|
|
2013 |
The Role of IL-6 Signaling in Cancer-induced Bone Pain |
$70,501 |
Research |
University of New England |
Bone |
|
|
2013 |
Improving the Treament of Cancer Related Pain |
$22,540 |
Research |
University of New England |
Bone |
|
|
2013 |
New Models for Lung Cancer Research |
$59,518 |
Research |
The Jackson Laboratory |
Lung |
 |
|
2012 |
Feasibility of Using SEER-Medicare Data to Assess the Influence of ESA Policy Changes on Outcomes |
$55,936 |
Research |
University of New England |
All |
|
|
2012 |
Inhibitory Effects of Insulin-like Growth Factor Binding Protein-4(IGFBP-4) on Melanoma Growth and Metastasis |
$73,848 |
Research |
Maine Medical Center |
Skin |
|
|
2012 |
The Role of IL-6 Signaling in Cancer-induced Bone Pain |
$69,132 |
Research |
University of New England |
Bone |
|
|
2012 |
Ddit4 Function in Radio-Resistance of Glicoma Stem Cells |
$84,000 |
Research |
The Jackson Laboratory |
All |
|
|
2012 |
The Role of IL-6 Signaling in Cancer-induced Bone Pain |
$69,132 |
Research |
University of New England |
Bone |
 |
|
2012 |
Ddit4 Function in Radio-Resistance of Glicoma Stem Cells |
$84,000 |
Research |
The Jackson Laboratory |
All |
|
|
2012 |
New Models for Lung Cancer Research |
$59,518 |
Research |
The Jackson Laboratory |
Lung |
|
|
2012 |
Development of a Cancer Staging Tool Based on Viscoelastic and Spectrosphic Properties of Cystic Fluids |
$75,422 |
Research |
University of Maine Orono |
Screening |
|
|
2012 |
Feasibility of Using SEER-Medicare Data to Assess the Influence of ESA Policy Changes on Outcomes |
$55,936 |
Research |
University of New England |
All |
|
|
2012 |
Inhibitory Effects of Insulin-like Growth Factor Binding Protein-4(IGFBP-4) on Melanoma Growth and Metastasis |
$73,848 |
Research |
Maine Medical Center |
Skin |
|
|
2012 |
Feasibility of Using SEER-Medicare Data to Assess the Influence of ESA Policy Changes on Outcomes |
$55,936 |
Research |
University of New England |
All |
 |
|
2012 |
Inhibitory Effects of Insulin-like Growth Factor Binding Protein-4(IGFBP-4) on Melanoma Growth and Metastasis |
$73,848 |
Research |
Maine Medical Center |
Skin |
 |
|
2012 |
3DMammoComp: Next Generation Computational Analysis of Breast Tomosynthesis |
$82,843 |
Research |
University of Maine Orono |
Breast |
|
|
2012 |
Improving Colorectal Cencer Screenings in Low-Income Primary Care Settings Using Shared Decision Making |
$97,860 |
Research |
Maine Medical Center |
Screening |
|
|
2012 |
New Models for Lung Cancer Research |
$59,518 |
Research |
The Jackson Laboratory |
Lung |
|
|
2012 |
Development of a Cancer Staging Tool Based on Viscoelastic and Spectrosphic Properties of Cystic Fluids |
$75,422 |
Research |
University of Maine Orono |
Screening |
|
|
2012 |
New Models for Lung Cancer Research |
$59,518 |
Research |
The Jackson Laboratory |
Lung |
|
|
2012 |
Development of a Cancer Staging Tool Based on Viscoelastic and Spectrosphic Properties of Cystic Fluids |
$75,422 |
Research |
University of Maine Orono |
Screening |
|
|
2012 |
The Role of IL-6 Signaling in Cancer-induced Bone Pain |
$69,132 |
Research |
University of New England |
Bone |
|
|
2012 |
Ddit4 Function in Radio-Resistance of Glicoma Stem Cells |
$84,000 |
Research |
The Jackson Laboratory |
All |
|
|
2012 |
3DMammoComp: Next Generation Computational Analysis of Breast Tomosynthesis |
$82,843 |
Research |
University of Maine Orono |
Breast |
|
|
2012 |
Improving Colorectal Cencer Screenings in Low-Income Primary Care Settings Using Shared Decision Making |
$97,860 |
Research |
Maine Medical Center |
Screening |
|
|
2012 |
3DMammoComp: Next Generation Computational Analysis of Breast Tomosynthesis |
$82,843 |
Research |
University of Maine Orono |
Breast |
|
|
2012 |
Improving Colorectal Cencer Screenings in Low-Income Primary Care Settings Using Shared Decision Making |
$97,860 |
Research |
Maine Medical Center |
Screening |
|
|
2011 |
Non-Psychotropic Cannabinoid2 Receptor Agonists Inhibit Breast Cancer Proliferation |
$105,197 |
Research |
University of New England |
Breast |
|
|
2011 |
Functional Analysis of Foxq1's Role in Tumor Vascularization |
$75,823 |
Research |
Mount Desert Biological Laboratory |
Cellular & Molecular |
|
|
2011 |
Imaging Glicoma Stem Cell Dynamics in Vivo |
$90,000 |
Research |
The Jackson Laboratory |
Screening |
|
|
2011 |
The Molecular Structor of Arm 1 |
$73,087 |
Research |
Maine Institue for Human Genetics and Health |
Cellular & Molecular |
|
|
2011 |
Inceptive Role of miR-199b in Acute Myeloid Leukemia |
$92,000 |
Research |
Maine Medical Center |
Leukemia |
|
|
2011 |
The Molecular Structor of Arm 1 |
$73,087 |
Research |
Maine Institue for Human Genetics and Health |
Cellular & Molecular |
|
|
2011 |
Inceptive Role of miR-199b in Acute Myeloid Leukemia |
$92,000 |
Research |
Maine Medical Center |
Leukemia |
|
|
2011 |
Notch Regulation of the Tumor Supressor miR-145 in Breast Cancer Cells |
$94,184 |
Research |
Maine Medical Center |
Breast |
|
|
2011 |
Small Molecule Inhibitors of Twist1 Function to Inhibit Tumor Progression |
$73,039 |
Research |
Maine Medical Center |
Cellular & Molecular |
|
|
2011 |
Validating Prediction Tools for Prostate Cancer Quality of Life Outcomes |
$71,029 |
Research |
Maine Medical Center |
Prostate |
|
|
2011 |
Non-Psychotropic Cannabinoid2 Receptor Agonists Inhibit Breast Cancer Proliferation |
$105,197 |
Research |
University of New England |
Breast |
|
|
2011 |
Functional Analysis of Foxq1's Role in Tumor Vascularization |
$75,823 |
Research |
Mount Desert Biological Laboratory |
Cellular & Molecular |
|
|
2011 |
Imaging Glicoma Stem Cell Dynamics in Vivo |
$90,000 |
Research |
The Jackson Laboratory |
Screening |
|
|
2011 |
Non-Psychotropic Cannabinoid2 Receptor Agonists Inhibit Breast Cancer Proliferation |
$105,197 |
Research |
University of New England |
Breast |
|
|
2011 |
Functional Analysis of Foxq1's Role in Tumor Vascularization |
$75,823 |
Research |
Mount Desert Biological Laboratory |
Cellular & Molecular |
|
|
2011 |
Imaging Glicoma Stem Cell Dynamics in Vivo |
$90,000 |
Research |
The Jackson Laboratory |
Screening |
|
|
2011 |
FGF Export from Endothelial Cells: Protumorigenic Potential and Methods of Regulation |
$86,877 |
Research |
Maine Medical Center |
Cellular & Molecular |
|
|
2011 |
Targeted SiRNA Inhibition of Vascular Endothelial Growth Factors in Lung Cancer Cells |
$69,000 |
Research |
Husson University |
Lung |
|
|
2011 |
Notch Regulation of the Tumor Supressor miR-145 in Breast Cancer Cells |
$94,184 |
Research |
Maine Medical Center |
Breast |
|
|
2011 |
Small Molecule Inhibitors of Twist1 Function to Inhibit Tumor Progression |
$73,039 |
Research |
Maine Medical Center |
Cellular & Molecular |
|
|
2011 |
Validating Prediction Tools for Prostate Cancer Quality of Life Outcomes |
$71,029 |
Research |
Maine Medical Center |
Prostate |
|
|
2011 |
Notch Regulation of the Tumor Supressor miR-145 in Breast Cancer Cells |
$94,184 |
Research |
Maine Medical Center |
Breast |
|
|
2011 |
Small Molecule Inhibitors of Twist1 Function to Inhibit Tumor Progression |
$73,039 |
Research |
Maine Medical Center |
Cellular & Molecular |
|
|
2011 |
Validating Prediction Tools for Prostate Cancer Quality of Life Outcomes |
$71,029 |
Research |
Maine Medical Center |
Prostate |
|
|
2011 |
The Molecular Structor of Arm 1 |
$73,087 |
Research |
Maine Institue for Human Genetics and Health |
Cellular & Molecular |
|
|
2011 |
Inceptive Role of miR-199b in Acute Myeloid Leukemia |
$92,000 |
Research |
Maine Medical Center |
Leukemia |
|
|
2011 |
FGF Export from Endothelial Cells: Protumorigenic Potential and Methods of Regulation |
$86,877 |
Research |
Maine Medical Center |
Cellular & Molecular |
|
|
2011 |
Targeted SiRNA Inhibition of Vascular Endothelial Growth Factors in Lung Cancer Cells |
$69,000 |
Research |
Husson University |
Lung |
|
|
2011 |
FGF Export from Endothelial Cells: Protumorigenic Potential and Methods of Regulation |
$86,877 |
Research |
Maine Medical Center |
Cellular & Molecular |
|
|
2011 |
Targeted SiRNA Inhibition of Vascular Endothelial Growth Factors in Lung Cancer Cells |
$69,000 |
Research |
Husson University |
Lung |
|
|
2010 |
Noth Signaling in Medulloblastoma Initiation and Cancer Stem Cell Maintenance |
$90,000 |
Research |
The Jackson Laboratory |
Cellular & Molecular |
|
|
2010 |
Targeting Stromal Cell Interactions to Reduce Prostate Cancer |
$81,175 |
Research |
Maine Medical Center Research Institute |
Prostate |
|
|
2010 |
Noth Signaling in Medulloblastoma Initiation and Cancer Stem Cell Maintenance |
$90,000 |
Research |
The Jackson Laboratory |
Cellular & Molecular |
|
|
2010 |
Targeting Stromal Cell Interactions to Reduce Prostate Cancer |
$81,175 |
Research |
Maine Medical Center Research Institute |
Prostate |
|
|
2010 |
Regulation of Hematopoietic Stem Cells by Heparin Binding Domain of IGFBP-2 |
$82,535 |
Research |
Maine Medical Center Research Institute |
Cellular & Molecular |
|
|
2010 |
MicroRNA Expression during Lung Timor Progression |
$90,000 |
Research |
The Jackson Laboratory |
Lung |
|
|
2010 |
Regulation of Hematopoietic Stem Cells by Heparin Binding Domain of IGFBP-2 |
$82,535 |
Research |
Maine Medical Center Research Institute |
Cellular & Molecular |
|
|
2010 |
MicroRNA Expression during Lung Timor Progression |
$90,000 |
Research |
The Jackson Laboratory |
Lung |
|
|
2010 |
Regulation of Hematopoietic Stem Cells by Heparin Binding Domain of IGFBP-2 |
$82,535 |
Research |
Maine Medical Center Research Institute |
Cellular & Molecular |
|
|
2010 |
MicroRNA Expression during Lung Timor Progression |
$90,000 |
Research |
The Jackson Laboratory |
Lung |
|
|
2010 |
Role of Cryptic Activation Site within B1 Integrins in Breast Tumor Growth |
$91,919 |
Research |
Maine Medical Center Research Institute |
Breast |
|
|
2010 |
Genetic Chemotherapy: Inducing Leukemia and Lymphoma Cell Self Destruction |
$67,500 |
Research |
The Jackson Laboratory |
Leukemia |
|
|
2010 |
Role of Cryptic Activation Site within B1 Integrins in Breast Tumor Growth |
$91,919 |
Research |
Maine Medical Center Research Institute |
Breast |
|
|
2010 |
Genetic Chemotherapy: Inducing Leukemia and Lymphoma Cell Self Destruction |
$67,500 |
Research |
The Jackson Laboratory |
Leukemia |
|
|
2010 |
Role of Cryptic Activation Site within B1 Integrins in Breast Tumor Growth |
$91,919 |
Research |
Maine Medical Center Research Institute |
Breast |
|
|
2010 |
Genetic Chemotherapy: Inducing Leukemia and Lymphoma Cell Self Destruction |
$67,500 |
Research |
The Jackson Laboratory |
Leukemia |
|
|
2010 |
Evaluating MicroRNA's as Prognostic Determinants in Stage II Colon Cancer |
$78,000 |
Research |
Maine Center for Cancer Medicine |
Colon |
|
|
2010 |
Computationaal Pathology: 3-d Analysis of Chromosome Territories |
$80,000 |
Research |
University of Maine Orono |
Screening |
|
|
2010 |
Evaluating MicroRNA's as Prognostic Determinants in Stage II Colon Cancer |
$78,000 |
Research |
Maine Center for Cancer Medicine |
Colon |
|
|
2010 |
Computationaal Pathology: 3-d Analysis of Chromosome Territories |
$80,000 |
Research |
University of Maine Orono |
Screening |
|
|
2010 |
Evaluating MicroRNA's as Prognostic Determinants in Stage II Colon Cancer |
$78,000 |
Research |
Maine Center for Cancer Medicine |
Colon |
|
|
2010 |
Computationaal Pathology: 3-d Analysis of Chromosome Territories |
$80,000 |
Research |
University of Maine Orono |
Screening |
|
|
2010 |
Noth Signaling in Medulloblastoma Initiation and Cancer Stem Cell Maintenance |
$90,000 |
Research |
The Jackson Laboratory |
Cellular & Molecular |
|
|
2010 |
Targeting Stromal Cell Interactions to Reduce Prostate Cancer |
$81,175 |
Research |
Maine Medical Center Research Institute |
Prostate |
|
|
2009 |
Functional Tests of PODXL's Contributions to Tumorigenesis |
$80,000 |
Research |
Maine Medical Center Research Institute |
Screening |
|
|
2009 |
Functional Tests of PODXL's Contributions to Tumorigenesis |
$80,000 |
Research |
Maine Medical Center Research Institute |
Screening |
|
|
2009 |
Predicting Quality of Life Outcomes after Prostate Cancer Treatment |
$45,295 |
Research |
Maine Medical Center |
Prostate |
|
|
2009 |
Predicting Quality of Life Outcomes after Prostate Cancer Treatment |
$45,295 |
Research |
Maine Medical Center |
Prostate |
|
|
2009 |
Predicting Quality of Life Outcomes after Prostate Cancer Treatment |
$45,295 |
Research |
Maine Medical Center |
Prostate |
|
|
2009 |
Role of MicroRNA-10b in Neurofibromatosis Type 1 Tumorigenesis and Progression |
$72,059 |
Research |
Maine Institute for Human Genetics and Health |
Cellular & Molecular |
|
|
2009 |
Role of MicroRNA-10b in Neurofibromatosis Type 1 Tumorigenesis and Progression |
$72,059 |
Research |
Maine Institute for Human Genetics and Health |
Cellular & Molecular |
|
|
2009 |
Role of MicroRNA-10b in Neurofibromatosis Type 1 Tumorigenesis and Progression |
$72,059 |
Research |
Maine Institute for Human Genetics and Health |
Cellular & Molecular |
|
|
2009 |
Validating S100A6 as a Novel Marker and Potential Therapeutic Target of Brain Cancer Stem Cells |
$80,000 |
Research |
The Jackson Laboratory |
Brain |
|
|
2009 |
Improved Cancer Detection through the use of Engineered Nanoparticle Bioconjugates |
$78,292 |
Research |
University of Maine Orono |
Screening |
|
|
2009 |
Validating S100A6 as a Novel Marker and Potential Therapeutic Target of Brain Cancer Stem Cells |
$80,000 |
Research |
The Jackson Laboratory |
Brain |
|
|
2009 |
Improved Cancer Detection through the use of Engineered Nanoparticle Bioconjugates |
$78,292 |
Research |
University of Maine Orono |
Screening |
|
|
2009 |
Validating S100A6 as a Novel Marker and Potential Therapeutic Target of Brain Cancer Stem Cells |
$80,000 |
Research |
The Jackson Laboratory |
Brain |
|
|
2009 |
Improved Cancer Detection through the use of Engineered Nanoparticle Bioconjugates |
$78,292 |
Research |
University of Maine Orono |
Screening |
|
